322 related articles for article (PubMed ID: 34440751)
21. Ultrasound delivery of a TrkA agonist confers neuroprotection to Alzheimer-associated pathologies.
Xhima K; Markham-Coultes K; Hahn Kofoed R; Saragovi HU; Hynynen K; Aubert I
Brain; 2022 Aug; 145(8):2806-2822. PubMed ID: 34919633
[TBL] [Abstract][Full Text] [Related]
22. A dual mechanism linking NGF/proNGF imbalance and early inflammation to Alzheimer's disease neurodegeneration in the AD11 anti-NGF mouse model.
Capsoni S; Brandi R; Arisi I; D'Onofrio M; Cattaneo A
CNS Neurol Disord Drug Targets; 2011 Aug; 10(5):635-47. PubMed ID: 21631402
[TBL] [Abstract][Full Text] [Related]
23. Pronerve growth factor induces angiogenesis via activation of TrkA: possible role in proliferative diabetic retinopathy.
Elshaer SL; Abdelsaid MA; Al-Azayzih A; Kumar P; Matragoon S; Nussbaum JJ; El-Remessy AB
J Diabetes Res; 2013; 2013():432659. PubMed ID: 23998130
[TBL] [Abstract][Full Text] [Related]
24. Proneurotrophins require endocytosis and intracellular proteolysis to induce TrkA activation.
Boutilier J; Ceni C; Pagdala PC; Forgie A; Neet KE; Barker PA
J Biol Chem; 2008 May; 283(19):12709-16. PubMed ID: 18299325
[TBL] [Abstract][Full Text] [Related]
25. Different responses of PC12 cells to different pro-nerve growth factor protein variants.
Soligo M; Albini M; Bertoli FL; Marzano V; Protto V; Bracci-Laudiero L; Minnone G; De Benedetti F; Chiaretti A; Mantuano E; Manni L
Neurochem Int; 2019 Oct; 129():104498. PubMed ID: 31278975
[TBL] [Abstract][Full Text] [Related]
26. Neurotrophic actions initiated by proNGF in adult sensory neurons may require peri-somatic glia to drive local cleavage to NGF.
Kalous A; Nangle MR; Anastasia A; Hempstead BL; Keast JR
J Neurochem; 2012 Aug; 122(3):523-36. PubMed ID: 22621370
[TBL] [Abstract][Full Text] [Related]
27. The nerve growth factor precursor proNGF exhibits neurotrophic activity but is less active than mature nerve growth factor.
Fahnestock M; Yu G; Michalski B; Mathew S; Colquhoun A; Ross GM; Coughlin MD
J Neurochem; 2004 May; 89(3):581-92. PubMed ID: 15086515
[TBL] [Abstract][Full Text] [Related]
28. Diminished trkA receptor signaling reveals cholinergic-attentional vulnerability of aging.
Parikh V; Howe WM; Welchko RM; Naughton SX; D'Amore DE; Han DH; Deo M; Turner DL; Sarter M
Eur J Neurosci; 2013 Jan; 37(2):278-93. PubMed ID: 23228124
[TBL] [Abstract][Full Text] [Related]
29. Biological activity of nerve growth factor precursor is dependent upon relative levels of its receptors.
Masoudi R; Ioannou MS; Coughlin MD; Pagadala P; Neet KE; Clewes O; Allen SJ; Dawbarn D; Fahnestock M
J Biol Chem; 2009 Jul; 284(27):18424-33. PubMed ID: 19389705
[TBL] [Abstract][Full Text] [Related]
30. The cholinergic system in aging and neuronal degeneration.
Schliebs R; Arendt T
Behav Brain Res; 2011 Aug; 221(2):555-63. PubMed ID: 21145918
[TBL] [Abstract][Full Text] [Related]
31. Epicatechin blocks pro-nerve growth factor (proNGF)-mediated retinal neurodegeneration via inhibition of p75 neurotrophin receptor expression in a rat model of diabetes [corrected].
Al-Gayyar MM; Matragoon S; Pillai BA; Ali TK; Abdelsaid MA; El-Remessy AB
Diabetologia; 2011 Mar; 54(3):669-80. PubMed ID: 21136036
[TBL] [Abstract][Full Text] [Related]
32. Pro-Nerve Growth Factor Induces Activation of RhoA Kinase and Neuronal Cell Death.
Sycheva M; Sustarich J; Zhang Y; Selvaraju V; Geetha T; Gearing M; Babu JR
Brain Sci; 2019 Aug; 9(8):. PubMed ID: 31430874
[TBL] [Abstract][Full Text] [Related]
33. Intrinsic structural disorder of mouse proNGF.
Paoletti F; Covaceuszach S; Konarev PV; Gonfloni S; Malerba F; Schwarz E; Svergun DI; Cattaneo A; Lamba D
Proteins; 2009 Jun; 75(4):990-1009. PubMed ID: 19089979
[TBL] [Abstract][Full Text] [Related]
34. Focused ultrasound delivery of a selective TrkA agonist rescues cholinergic function in a mouse model of Alzheimer's disease.
Xhima K; Markham-Coultes K; Nedev H; Heinen S; Saragovi HU; Hynynen K; Aubert I
Sci Adv; 2020 Jan; 6(4):eaax6646. PubMed ID: 32010781
[TBL] [Abstract][Full Text] [Related]
35. The precursor pro-nerve growth factor is the predominant form of nerve growth factor in brain and is increased in Alzheimer's disease.
Fahnestock M; Michalski B; Xu B; Coughlin MD
Mol Cell Neurosci; 2001 Aug; 18(2):210-20. PubMed ID: 11520181
[TBL] [Abstract][Full Text] [Related]
36. Deletion of p75
Elshaer SL; El-Remessy AB
Sci Rep; 2018 Aug; 8(1):12490. PubMed ID: 30131506
[TBL] [Abstract][Full Text] [Related]
37. ProNGF increases breast tumor aggressiveness through functional association of TrkA with EphA2.
Lévêque R; Corbet C; Aubert L; Guilbert M; Lagadec C; Adriaenssens E; Duval J; Finetti P; Birnbaum D; Magné N; Chopin V; Bertucci F; Le Bourhis X; Toillon RA
Cancer Lett; 2019 May; 449():196-206. PubMed ID: 30771434
[TBL] [Abstract][Full Text] [Related]
38. Sortilin is essential for proNGF-induced neuronal cell death.
Nykjaer A; Lee R; Teng KK; Jansen P; Madsen P; Nielsen MS; Jacobsen C; Kliemannel M; Schwarz E; Willnow TE; Hempstead BL; Petersen CM
Nature; 2004 Feb; 427(6977):843-8. PubMed ID: 14985763
[TBL] [Abstract][Full Text] [Related]
39. Expression and Prognostic Significance of Neurotrophins and Their Receptors in Canine Mammary Tumors.
Rogez B; Pascal Q; Bobillier A; Machuron F; Toillon RA; Tierny D; Chopin V; Le Bourhis X
Vet Pathol; 2020 Jul; 57(4):507-519. PubMed ID: 32351171
[TBL] [Abstract][Full Text] [Related]
40. Nerve growth factor in metabolic complications and Alzheimer's disease: Physiology and therapeutic potential.
Ding XW; Li R; Geetha T; Tao YX; Babu JR
Biochim Biophys Acta Mol Basis Dis; 2020 Oct; 1866(10):165858. PubMed ID: 32531260
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
